Abstract
Randomized trials have shown that stool testing for occult blood and flexible sigmoidoscopy reduce colorectal cancer (CRC) incidence and mortality, and based on observational evidence of its effectiveness, colonoscopy is also frequently used as a screening modality.1 Opportunistic and organized CRC screenings are now available in many countries, presenting opportunities for knowledge exchange and data sharing that could improve the delivery of screening and further reduce CRC morbidity and mortality worldwide.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
